KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $260 | -99.9% | 8,772 | +1.7% | 0.00% | +50.0% |
Q3 2022 | $188,000 | -74.4% | 8,629 | -76.9% | 0.00% | -75.0% |
Q2 2022 | $735,000 | +146.6% | 37,345 | +430.2% | 0.01% | +300.0% |
Q1 2022 | $298,000 | -55.6% | 7,044 | -33.4% | 0.00% | -50.0% |
Q4 2021 | $671,000 | -32.4% | 10,576 | -37.4% | 0.00% | -20.0% |
Q3 2021 | $993,000 | +480.7% | 16,903 | +379.9% | 0.01% | +400.0% |
Q2 2021 | $171,000 | +9.6% | 3,522 | -12.2% | 0.00% | 0.0% |
Q1 2021 | $156,000 | – | 4,010 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |